Brad Gerstner: The $100 Test That Could Save 50,000 Lives a Year

1. Key Themes

Regulatory Capture Explains a 50-Year Medical Blind Spot

Gerstner argues the reason calcium CT scanning isn't standard care today traces back to a lobbying battle decades ago between two competing approaches to heart disease. "There is a regulatory capture. So, 50 years ago... There was a race in Silicon Valley to see who could solve heart health. One path that people went down was to invent the stent. The other one was the calcium CT scanner. Who do you think won the lobby in Washington? The stent lobby won." 00:05:44

Cholesterol Is an Inadequate, Even Misleading, Health Marker

The episode's central medical claim is that the entire population health system has been built around a test that fails roughly half the time for the exact outcome it's meant to prevent. "It turns out that half of the people who have heart attacks every year have cholesterol in the normal zone." 00:21:17

Data as Power: Health Wearables Are Softening Resistance to Diagnostic Testing

Gerstner ties the growing embrace of scary-but-actionable health data to the broader consumer shift toward quantified self via wearables. "I find that increasingly because people have aura rings on, they have Apple watches on, right? We're breaking down the barriers to health data. People now want health data... Data is power." 00:10:27

The Mammogram Playbook Is a Reusable Template for Preventative Medicine

Gerstner explicitly frames breast cancer screening infrastructure as the model to replicate for heart disease, given the scale mismatch relative to actual mortality. "This kills eight hundred thousand people a year... I think we have about 40,000 people a year die of breast cancer. Eight hundred thousand people die of heart health. And yet we have 40 times as many mammograms as we have calcium CTs... I would like to copy that playbook for heart health." 00:19:27

Insurance Coverage Is the Real Lever for Standard-of-Care Change

Rather than relying on grassroots awareness alone, Gerstner is working the policy angle because reimbursement — not evidence — determines physician behavior at scale. "I think by the end of this year... CAC scans for diagnostic purposes, I think it will be approved and covered by Medicaid and Medicare. If that happens, then that's how it becomes a standard of care. Because doctors ultimately treat standard of care based upon what's covered by insurance." 00:11:22

Silicon Valley's "Bias to Action" Applied to Public Health, Not Just Startups

Gerstner frames this as an extension of startup-world instincts — movement-building and direct action — applied to a systemic health failure rather than sitting back and complaining about it. "We don't have to sit here as though we can do nothing. We have agency. Why aren't we doing 40 million CAC scans a year?... We start movements. Do things. We start companies. We do things. We have agency. We have a biased action." 00:03:55

Personal Tragedy as the Engine of the Moonshot

Both Gerstner (his father) and Rob Goldberg (his brother Dave) had close family members die of preventable, undiagnosed heart disease, and this personal loss — not a market opportunity — is explicitly identified as the founding motivation. "My father died too early from heart disease. So, I hijacked a session, the science corner on the All In Podcast in 2022 is when I first started talking about this." 00:06:14

2. Contrarian Perspectives

Standard Cardiac Screening (EKGs, Cholesterol, Stress Tests) Gives False Confidence

Goldberg's brother passed a running EKG five months before dying and had access to "top medical, concierge doctors" — yet still died completely undiagnosed. "Unfortunately, EKGs have a 4% either false positive or false negative where he had actually done so much cardio that he taught his heart to overcome the heart disease... he died of ventricular arrhythmia." 00:02:41

A "Normal" Cholesterol Reading Doesn't Mean You're Safe

This directly contradicts decades of public health messaging that treats cholesterol as the primary risk indicator. "I was in the green zone at 100. You feel good... You're good. You're in the green zone... Wrong." 00:09:09

The Medical Establishment's Public Guidance Diverges From What Its Own Experts Do Privately

Gerstner claims that when he stripped away "corporate speak" from heads of preventative cardiology at Stanford, Harvard, and Columbia, their personal practices contradicted official national guidelines. "What do you do for yourself, your friends, and your family?... every single one of them said at 30 or 35, I have them all take a CAC. If they have a non-zero score, I get them on a statin. I get their LDLs below 40, which is way below the national standards." 00:09:09

Labs Looking "Great" Can Coexist With a Fatal, Undetected Condition

The NuVo technician relays a case where full lab work gave zero warning before a massive heart attack, reinforcing that lab-based screening alone is structurally insufficient. "His lab looked great. However, he had a massive, massive heart attack, completely unknown. And he never had one of these done. So going just simply based on labs isn't enough." 00:20:11

3. Companies Identified

Clearly — An AI radiology service that sits on top of angiogram/CT imaging to provide refined stenosis readings. Mentioned as the tool Gerstner used to analyze and publicly share his own heart scan results. "Now we have great AIs like Clearly and other services that can sit on top of this. They're radiologists, AI radiologists that get really refined readings." 00:13:27 "I shared on Twitter a picture of my heart, right, through Clearly so that everybody could see exactly my level of stenosis." 00:13:56

Siemens — Manufacturer of the calcium CT scanning equipment used in the mobile trailer; cited as proven, mature medical technology. "This is pretty standard equipment. Siemens, CACs, you know, calcium CT scanners have been around for a long time, proven technology." 00:17:02

NuVo (referenced as "pre-Nuvo scan") — A full-body scanning provider Gerstner and Molly O'Shea both previously used, contrasted unfavorably on speed/experience versus the dedicated calcium CT scan. "Pre-nuvos take a long time, a lot of banging, et cetera." 00:16:36

Salesforce — Cited as a target for the "buy one, give one" corporate model, where the company would pay double to provide free CAC scans to all employees. "We could get Mark Benioff and Salesforce to give it to all of his employees for free. And then he would pay twice as much." 00:14:47

All In Podcast / BG2 Pod — Referenced as the media platforms Gerstner used to originally launch and sustain public awareness of the heart-health moonshot, crediting the podcast format itself with driving thousands of people to get scanned. "I hijacked a session, the science corner on the All In Podcast in 2022 is when I first started talking about this... I started getting hundreds and then thousands of letters." 00:06:14

4. People Identified

Brad Gerstner — Investor (Altimeter Capital) and founder of the Center for Heart Attack Prevention moonshot; personally lost his father to heart disease and has since scanned/influenced 40-50 members of Congress. "I probably now am responsible for 40 or 50 members of the House and the Senate having taken the CAC scan." 00:15:51

Rob Goldberg — Brother of Dave Goldberg (former SurveyMonkey CEO) and brother-in-law of Sheryl Sandberg; performed CPR on Dave after finding him collapsed, and is now a public advocate for cardiac screening. "My brother had passed a running EKG five months before he dropped dead from heart disease, from undiagnosed heart disease." 00:02:41

Dave Goldberg — Late CEO of SurveyMonkey, described as a beloved connector who was foundational to the origins of the "Bestie" group behind the All In Podcast; died at 47 of undiagnosed heart disease. "Dave was such a legend. So loved. The inspiration in many ways for All In and the Bestie group... he was the original, you know, who got everybody together." 00:03:40

Sheryl Sandberg — Former Meta COO, Dave Goldberg's widow, author of Option B about grief following his death; mentioned as instrumental in securing a full autopsy that identified the underlying heart disease. "So this is my sister-in-law is Sheryl Sandberg. She wrote a book called Option B about his death and about grieving." 00:02:12

Chamath Palihapitiya — Credited (alongside Sandberg) with helping ensure Dave Goldberg received a full autopsy after his death. "Thankfully to Cheryl, to Chamath, to some other folks, we got him back to be able to do a full autopsy and found his heart disease." 00:03:10

Bill Gurley — Referenced as a source/validator for the regulatory-capture history behind why stents beat calcium CT scanning in the medical establishment. "If Bill Gurley was here, okay?... there is a regulatory capture." 00:05:44

Jason Chang (Jason Calacanis, likely garbled) — Co-collaborator with Gerstner on the heart-health initiative and the Trump accounts effort. "Along with Jason Chang and the rest of the besties." 00:01:38

Dr. Mehmet Oz — Mentioned as a Washington contact Gerstner has met with multiple times to advance Medicare/Medicaid coverage for CAC scans. "I met with Dr. Oz now several times." 00:11:22

Dr. Mark Hyman — Cited for advocating longitudinal (repeated over time) cardiac scanning rather than a single one-off test. "Dr. Mark Hyman and Dr. Siddickson actually brought up longitudinal data." 00:20:11

Dr. Siddickson — Co-cited alongside Dr. Hyman on the importance of longitudinal scanning data tied to genetics and lab values.

Phil Deutsch — Friend referenced as host of the 50th birthday trip where Dave Goldberg died. "We were on vacation for a friend's 50th birthday. Another bestie, Phil Deutsch." 00:01:48

5. Operating Insights

Convert an Abstract Cause Into a Physical, Portable Artifact

Rather than just talking about the cause on a podcast, Gerstner bought a literal mobile scanning trailer to make the moonshot tangible, repeatable, and shareable at events — a physical distribution mechanism for an awareness campaign. "I rented a trailer for my investor day at the Rosewood and that was too much of a hassle. So I said, let's just buy one of these." 00:14:47

Engineer a Matching-Incentive Model to Scale Corporate Adoption

Gerstner designed a "buy one, give one" mechanic that doubles the unit price paid by wealthy companies in exchange for underwriting free access for underserved populations — a pricing/incentive structure that turns willingness-to-pay into cross-subsidized distribution. "Instead of paying a hundred, he would pay 200. And then we could go give free CAC scans in East Palo Alto and other neighborhoods where they couldn't afford it." 00:15:16

Target High-Leverage, High-Visibility Populations to Compound Word-of-Mouth

By specifically scanning Silicon Valley CEOs and members of Congress rather than the general public first, Gerstner engineered outsized downstream advocacy from people with reach and legislative power. "Famous CEOs in Silicon Valley found 98% blockage and had three stents put in within three weeks of having the CAC done." 00:06:42 "They are a target rich population... people are dismissive of it until they find something or their family find something. And then they become very devoted." 00:15:51

Interview Practitioners on Their Personal Behavior, Not Their Institutional Position

Gerstner's method for extracting real signal from experts was to explicitly reject institutional messaging and ask what they do for their own families — a repeatable technique for surfacing ground truth that differs from public guidance. "I don't want to hear the corporate speak. What do you do for yourself, your friends, and your family?" 00:09:09

6. Overlooked Insights

The Throughput Number Reveals This Is Already a Solved Logistics Problem, Not Just an Awareness Problem

Buried in a quick technical exchange is a concrete capacity figure — 33 scans in nine hours from a single trailer — that implies the real constraint on reaching "40 million CAC scans a year" is closer to a distribution/insurance problem than a technology or capacity problem. "So yesterday, in about a nine-hour window, we did 33." 00:17:28 With reimbursement secured, this suggests the scan itself could be deployed at a scale similar to mobile blood-donation units — a potentially investable logistics/infrastructure opportunity adjacent to the medical device itself.

Genetic Predisposition at a Young Age Is a More Alarming Signal Than the Same Score in an Older Patient — Implying an Underserved Segment

Gerstner notes, almost in passing, that a non-zero calcium score in a 30-year-old is far more diagnostically significant than the same finding in a 60-year-old, since it implies early-onset plaque accumulation over a much longer future horizon. "A 30 year old is less likely to have plaque buildup. But if they do have plaque, it's a lot more telling because that means they're gathering plaque early." 00:18:58 This implies the current mammogram-style "over 40" screening framing may be mistargeted, and that a younger-cohort screening product (positioned around genetic risk rather than age) could be a differentiated, underexploited niche.